Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Regulation of epitope exposure in the gp41 membrane-proximal external region through interactions at the apex of HIV-1 Env.

PLoS pathogens·2022

Same author

Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators.

Retrovirology·2021

Same author

Characterization of resistance to a potent D-peptide HIV entry inhibitor.

Retrovirology·2019

Same author

Complex interplay of kinetic factors governs the synergistic properties of HIV-1 entry inhibitors.

The Journal of biological chemistry·2017

Same author

Receptor Activation of HIV-1 Env Leads to Asymmetric Exposure of the gp41 Trimer.

PLoS pathogens·2016

Same author

Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus.

PLoS pathogens·2016

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

Implantable cardiac rhythm device batteries.

Michael J Root¹

¹Boston Scientific Corp., 4100 Hamline Avenue North, St. Paul, MN 55112, USA. michael.root@bsci.com

Journal of Cardiovascular Translational Research

|June 19, 2010

Summary

New battery designs provide greater power and longevity for implantable cardiac devices like pacemakers. These advancements ensure reliable energy for improved patient treatment and device performance.

Area of Science:

Biomedical Engineering
Materials Science

Background:

Implantable cardiac rhythm devices, including pacemakers and defibrillators, are crucial for managing cardiomyopathies.
These devices rely entirely on internal batteries for operational energy.

Purpose of the Study:

To describe advancements in battery technology for implantable cardiac rhythm devices.
To highlight the evolution of batteries in response to device development.

Main Methods:

Review of battery design principles for cardiac implantable electronic devices.
Analysis of the relationship between device features and battery requirements.

Main Results:

Batteries have been engineered for increased energy and power density.

More Related Videos

Implantation of the Syncardia Total Artificial Heart

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Related Experiment Videos

Last Updated: Jun 12, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

Implantation of the Syncardia Total Artificial Heart

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

New concepts have led to smaller, more reliable batteries with enhanced longevity and output.

Conclusions:

Battery innovations are critical for the continued development of sophisticated cardiac rhythm management devices.
Improved battery technology directly supports longer device life and enhanced functionality for patient care.